Korea Atomic Energy Research Institute

Beom Su Jang

Sang Hyun Park

Byung Chul Shin

Kyung Bae Park

Sang Mu Choi

Sun Ju Choi

Hui Jeong Gwon

Dae Seong Choi

Young Don Hong

Woong Woo Park

Kwang Hee Han

Dong Eun Lee

Sajid Mushtaq

Ha Eun Sim

Eui-Baek Byun

Seong Jae Yun

Jong Ho Jeon

Jongho Jeon

Eui Baek Byun

Dong-Eun Lee

YouRee Nam

Mi Hee Choi

The present disclosure relates to a method for labeling a radioisotope, a radiolabeling compound, a kit including the same, and a method for labeling a radioisotope, including: providing a diaminophenyl compound represented by Chemical Formula I below and including a biomolecule, a fluorescent dye or a nanoparticle compound bound thereto; and reacting the diaminophenyl compound and a radioisotope-labeled aldehyde compound represented by Chemical Formula II below at room temperature; and a related technology:    

Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope

A process for removing iodine using gold particles includes contacting a solution including iodine, with gold particles. The iodine is adsorbed onto the gold particles and then removed. A device for removing iodine using gold particles includes gold particles in a stationary phase and is configured to contact a solution including iodine, with gold particles, to thus adsorb the iodine onto the gold particles and remove the iodine.

Process and device for removing iodine using gold particles

The present invention relates to a pharmaceutical composition for the prevention and treatment of tissue injury caused by irradiation which comprises silkworm hemolymph as an active ingredient. Particularly, when the silkworm hemolymph of the present invention was administered to an animal model with liver damage induced by irradiation, plasma AST and liver MDA were significantly decreased, indicating that the silkworm hemolymph of the invention can be effectively used as a composition for the prevention and treatment of disease caused by the exposure on radiation including tissue injury caused by irradiation, etc.

Pharmaceutical composition comprising silkworm as an active ingredient for prevention and treatment of tissue injury by radiation

A method for labelling a sulfide compound with technetium or rhenium, comprising the reaction of a disulfide compound with pertechnetate or perrhenate in the presence of borohydride exchange resin to obtain a complex of technetium or rhenium with the sulfide compound. The method can directly label disulfide compounds with technetium or rhenium, can skip the synthetic step of thiol-protected S-precursor, and is useful for high value-added radiopharmaceuticals.

Method for labelling technetium or rhenium using borohydride exchange resin

The present invention relates to a method of preparing technetium or rhenium complex for radiopharmaceuticals, through reaction of pertechnetate or perrhenate with a ligand in the presence of a reducing agent, wherein the reducing agent is a borohydride exchange resin (BER). The borohydride exchange resin of the present invention has advantages of being stable in a wide range of Ph, including acidic or alkaline condition(Ph 2&#x2dc;14) and thus being applicable to biological materials as well as being easily removable through filtration when being administrated. Also since the radiolabelled complex is produced under conditions milder than those required for the conventional reducing agents as well as has high radiochemical purity and high labeling efficiency, the conventional reducing agents can be replaced by the BER of the present invention.

Method for the preparation of technetium or rhenium complex for radiopharmaceuticals

Growing community of inventors

Daejeon, South Korea

Beom Su Jang